Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure

•Rats were exposed to soman to induce status epilepticus (SE).•AChE activity was measured in piriform cortex, hippocampus, and basolateral amygdala.•AChE was reduced in all three brain regions of rats that developed SE.•A small percentage of rats did not develop SE.•AChE was not reduced in the basol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotoxicology (Park Forest South) 2013-09, Vol.38, p.84-90
Hauptverfasser: Prager, Eric M., Aroniadou-Anderjaska, Vassiliki, Almeida-Suhett, Camila P., Figueiredo, Taiza H., Apland, James P., Braga, Maria F.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 90
container_issue
container_start_page 84
container_title Neurotoxicology (Park Forest South)
container_volume 38
creator Prager, Eric M.
Aroniadou-Anderjaska, Vassiliki
Almeida-Suhett, Camila P.
Figueiredo, Taiza H.
Apland, James P.
Braga, Maria F.M.
description •Rats were exposed to soman to induce status epilepticus (SE).•AChE activity was measured in piriform cortex, hippocampus, and basolateral amygdala.•AChE was reduced in all three brain regions of rats that developed SE.•A small percentage of rats did not develop SE.•AChE was not reduced in the basolateral amygdala of rats that did not develop SE. Exposure to nerve agents induces intense seizures (status epilepticus, SE), which cause brain damage or death. Identification of the brain regions that are critical for seizure initiation after nerve agent exposure, along with knowledge of the physiology of these regions, can facilitate the development of pretreatments and treatments that will successfully prevent or limit the development of seizures and brain damage. It is well-established that seizure initiation is due to excessive cholinergic activity triggered by the nerve agent-induced irreversible inhibition of acetylcholinesterase (AChE). Therefore, the reason that when animals are exposed to lethal doses of a nerve agent, a small proportion of these animals do not develop seizures, may have to do with failure of the nerve agent to inhibit AChE in brain areas that play a key role in seizure initiation and propagation. In the present study, we compared AChE activity in the basolateral amygdala (BLA), hippocampus, and piriform cortex of rats that developed SE (SE rats) after administration of the nerve agent soman (154μg/kg) to AChE activity in these brain regions of rats that received the same dose of soman but did not develop SE (no-SE rats). The levels of AChE activity were measured at the onset of SE in SE rats, 30min after soman administration in no-SE rats, as well as in controls which received saline in place of soman. In the control group, AChE activity was significantly higher in the BLA compared to the hippocampus and piriform cortex. Compared to controls, AChE activity was dramatically lower in the hippocampus and the piriform cortex of both the SE rats and the no-SE rats, but AChE activity in the BLA was reduced only in the SE rats. Consistent with the notion that soman-induced neuropathology is due to intense seizures, rather than due to a direct neurotoxic effect of soman, no-SE rats did not present any neuronal loss or degeneration, 7 days after exposure. The results suggest that inhibition of AChE activity in the BLA is necessary for the generation of seizures after nerve agent exposure, and provide strong support to the view that the amygdala
doi_str_mv 10.1016/j.neuro.2013.06.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1676357028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161813X13001113</els_id><sourcerecordid>1676357028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-75a9236879f7c150f99f26022d8f55ea8639864a155cb48445cdf090772e56703</originalsourceid><addsrcrecordid>eNqFkcuKFDEUhoMoTjv6BIJkI7ipNpfKpRYuhsEbDLhRcBfSqRM7bapSJlWD9QY-tunpHt3pKgfy_Scn50PoOSVbSqh8fdiOsOS0ZYTyLZFbQuQDtKFasaZTlD5Em0rRRlP-9QI9KeVACBVKdo_RBeOaKqrEBv26cjCv0e1TDCOUGbItgMO4D7swhzTWEs97wDtbUrTH64jtsH7rbbR4inYt2OLvsOKcItzDYewXd5dOHpfZzkvBMIUI0xxcra2vjXBJgx0x_JxSWTI8RY-8jQWenc9L9OXd28_XH5qbT-8_Xl_dNK5VbG6UsB3jUqvOK0cF8V3nmSSM9doLAVZL3mnZWiqE27W6bYXrPemIUgyEVIRfolenvlNOP5b6YzOE4iBGO0JaiqFSSS4UYfr_aMvrgqXUvKL8hLqcSsngzZTDYPNqKDFHW-Zg7myZoy1DpKm2aurF-YFlN0D_J3OvpwIvz4Atzkaf7ehC-csppTrF28q9OXFQN3cbIJviAowO-pDBzaZP4Z-D_AZ3w7V6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1431616683</pqid></control><display><type>article</type><title>Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Prager, Eric M. ; Aroniadou-Anderjaska, Vassiliki ; Almeida-Suhett, Camila P. ; Figueiredo, Taiza H. ; Apland, James P. ; Braga, Maria F.M.</creator><creatorcontrib>Prager, Eric M. ; Aroniadou-Anderjaska, Vassiliki ; Almeida-Suhett, Camila P. ; Figueiredo, Taiza H. ; Apland, James P. ; Braga, Maria F.M.</creatorcontrib><description>•Rats were exposed to soman to induce status epilepticus (SE).•AChE activity was measured in piriform cortex, hippocampus, and basolateral amygdala.•AChE was reduced in all three brain regions of rats that developed SE.•A small percentage of rats did not develop SE.•AChE was not reduced in the basolateral amygdala of rats that did not develop SE. Exposure to nerve agents induces intense seizures (status epilepticus, SE), which cause brain damage or death. Identification of the brain regions that are critical for seizure initiation after nerve agent exposure, along with knowledge of the physiology of these regions, can facilitate the development of pretreatments and treatments that will successfully prevent or limit the development of seizures and brain damage. It is well-established that seizure initiation is due to excessive cholinergic activity triggered by the nerve agent-induced irreversible inhibition of acetylcholinesterase (AChE). Therefore, the reason that when animals are exposed to lethal doses of a nerve agent, a small proportion of these animals do not develop seizures, may have to do with failure of the nerve agent to inhibit AChE in brain areas that play a key role in seizure initiation and propagation. In the present study, we compared AChE activity in the basolateral amygdala (BLA), hippocampus, and piriform cortex of rats that developed SE (SE rats) after administration of the nerve agent soman (154μg/kg) to AChE activity in these brain regions of rats that received the same dose of soman but did not develop SE (no-SE rats). The levels of AChE activity were measured at the onset of SE in SE rats, 30min after soman administration in no-SE rats, as well as in controls which received saline in place of soman. In the control group, AChE activity was significantly higher in the BLA compared to the hippocampus and piriform cortex. Compared to controls, AChE activity was dramatically lower in the hippocampus and the piriform cortex of both the SE rats and the no-SE rats, but AChE activity in the BLA was reduced only in the SE rats. Consistent with the notion that soman-induced neuropathology is due to intense seizures, rather than due to a direct neurotoxic effect of soman, no-SE rats did not present any neuronal loss or degeneration, 7 days after exposure. The results suggest that inhibition of AChE activity in the BLA is necessary for the generation of seizures after nerve agent exposure, and provide strong support to the view that the amygdala is a key brain region for the induction of seizures by nerve agents.</description><identifier>ISSN: 0161-813X</identifier><identifier>EISSN: 1872-9711</identifier><identifier>DOI: 10.1016/j.neuro.2013.06.006</identifier><identifier>PMID: 23817175</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Acetylcholinesterase ; Amygdala - drug effects ; Amygdala - enzymology ; Animals ; Basolateral amygdala ; Biological and medical sciences ; Brain - drug effects ; Brain - pathology ; Chemical and industrial products toxicology. Toxic occupational diseases ; Cholinesterase Inhibitors - toxicity ; Gas, fumes ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - enzymology ; Male ; Medical sciences ; Nerve Degeneration - chemically induced ; Nervous system (semeiology, syndromes) ; Neurology ; Olfactory Pathways - enzymology ; Piriform cortex ; Rats ; Soman ; Soman - toxicity ; Status epilepticus ; Status Epilepticus - chemically induced ; Status Epilepticus - enzymology ; Status Epilepticus - pathology ; Toxicology</subject><ispartof>Neurotoxicology (Park Forest South), 2013-09, Vol.38, p.84-90</ispartof><rights>2013</rights><rights>2014 INIST-CNRS</rights><rights>Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-75a9236879f7c150f99f26022d8f55ea8639864a155cb48445cdf090772e56703</citedby><cites>FETCH-LOGICAL-c472t-75a9236879f7c150f99f26022d8f55ea8639864a155cb48445cdf090772e56703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161813X13001113$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27779734$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23817175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prager, Eric M.</creatorcontrib><creatorcontrib>Aroniadou-Anderjaska, Vassiliki</creatorcontrib><creatorcontrib>Almeida-Suhett, Camila P.</creatorcontrib><creatorcontrib>Figueiredo, Taiza H.</creatorcontrib><creatorcontrib>Apland, James P.</creatorcontrib><creatorcontrib>Braga, Maria F.M.</creatorcontrib><title>Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure</title><title>Neurotoxicology (Park Forest South)</title><addtitle>Neurotoxicology</addtitle><description>•Rats were exposed to soman to induce status epilepticus (SE).•AChE activity was measured in piriform cortex, hippocampus, and basolateral amygdala.•AChE was reduced in all three brain regions of rats that developed SE.•A small percentage of rats did not develop SE.•AChE was not reduced in the basolateral amygdala of rats that did not develop SE. Exposure to nerve agents induces intense seizures (status epilepticus, SE), which cause brain damage or death. Identification of the brain regions that are critical for seizure initiation after nerve agent exposure, along with knowledge of the physiology of these regions, can facilitate the development of pretreatments and treatments that will successfully prevent or limit the development of seizures and brain damage. It is well-established that seizure initiation is due to excessive cholinergic activity triggered by the nerve agent-induced irreversible inhibition of acetylcholinesterase (AChE). Therefore, the reason that when animals are exposed to lethal doses of a nerve agent, a small proportion of these animals do not develop seizures, may have to do with failure of the nerve agent to inhibit AChE in brain areas that play a key role in seizure initiation and propagation. In the present study, we compared AChE activity in the basolateral amygdala (BLA), hippocampus, and piriform cortex of rats that developed SE (SE rats) after administration of the nerve agent soman (154μg/kg) to AChE activity in these brain regions of rats that received the same dose of soman but did not develop SE (no-SE rats). The levels of AChE activity were measured at the onset of SE in SE rats, 30min after soman administration in no-SE rats, as well as in controls which received saline in place of soman. In the control group, AChE activity was significantly higher in the BLA compared to the hippocampus and piriform cortex. Compared to controls, AChE activity was dramatically lower in the hippocampus and the piriform cortex of both the SE rats and the no-SE rats, but AChE activity in the BLA was reduced only in the SE rats. Consistent with the notion that soman-induced neuropathology is due to intense seizures, rather than due to a direct neurotoxic effect of soman, no-SE rats did not present any neuronal loss or degeneration, 7 days after exposure. The results suggest that inhibition of AChE activity in the BLA is necessary for the generation of seizures after nerve agent exposure, and provide strong support to the view that the amygdala is a key brain region for the induction of seizures by nerve agents.</description><subject>Acetylcholinesterase</subject><subject>Amygdala - drug effects</subject><subject>Amygdala - enzymology</subject><subject>Animals</subject><subject>Basolateral amygdala</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - pathology</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Cholinesterase Inhibitors - toxicity</subject><subject>Gas, fumes</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - enzymology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nerve Degeneration - chemically induced</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Olfactory Pathways - enzymology</subject><subject>Piriform cortex</subject><subject>Rats</subject><subject>Soman</subject><subject>Soman - toxicity</subject><subject>Status epilepticus</subject><subject>Status Epilepticus - chemically induced</subject><subject>Status Epilepticus - enzymology</subject><subject>Status Epilepticus - pathology</subject><subject>Toxicology</subject><issn>0161-813X</issn><issn>1872-9711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcuKFDEUhoMoTjv6BIJkI7ipNpfKpRYuhsEbDLhRcBfSqRM7bapSJlWD9QY-tunpHt3pKgfy_Scn50PoOSVbSqh8fdiOsOS0ZYTyLZFbQuQDtKFasaZTlD5Em0rRRlP-9QI9KeVACBVKdo_RBeOaKqrEBv26cjCv0e1TDCOUGbItgMO4D7swhzTWEs97wDtbUrTH64jtsH7rbbR4inYt2OLvsOKcItzDYewXd5dOHpfZzkvBMIUI0xxcra2vjXBJgx0x_JxSWTI8RY-8jQWenc9L9OXd28_XH5qbT-8_Xl_dNK5VbG6UsB3jUqvOK0cF8V3nmSSM9doLAVZL3mnZWiqE27W6bYXrPemIUgyEVIRfolenvlNOP5b6YzOE4iBGO0JaiqFSSS4UYfr_aMvrgqXUvKL8hLqcSsngzZTDYPNqKDFHW-Zg7myZoy1DpKm2aurF-YFlN0D_J3OvpwIvz4Atzkaf7ehC-csppTrF28q9OXFQN3cbIJviAowO-pDBzaZP4Z-D_AZ3w7V6</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Prager, Eric M.</creator><creator>Aroniadou-Anderjaska, Vassiliki</creator><creator>Almeida-Suhett, Camila P.</creator><creator>Figueiredo, Taiza H.</creator><creator>Apland, James P.</creator><creator>Braga, Maria F.M.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20130901</creationdate><title>Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure</title><author>Prager, Eric M. ; Aroniadou-Anderjaska, Vassiliki ; Almeida-Suhett, Camila P. ; Figueiredo, Taiza H. ; Apland, James P. ; Braga, Maria F.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-75a9236879f7c150f99f26022d8f55ea8639864a155cb48445cdf090772e56703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetylcholinesterase</topic><topic>Amygdala - drug effects</topic><topic>Amygdala - enzymology</topic><topic>Animals</topic><topic>Basolateral amygdala</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - pathology</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Cholinesterase Inhibitors - toxicity</topic><topic>Gas, fumes</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - enzymology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nerve Degeneration - chemically induced</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Olfactory Pathways - enzymology</topic><topic>Piriform cortex</topic><topic>Rats</topic><topic>Soman</topic><topic>Soman - toxicity</topic><topic>Status epilepticus</topic><topic>Status Epilepticus - chemically induced</topic><topic>Status Epilepticus - enzymology</topic><topic>Status Epilepticus - pathology</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prager, Eric M.</creatorcontrib><creatorcontrib>Aroniadou-Anderjaska, Vassiliki</creatorcontrib><creatorcontrib>Almeida-Suhett, Camila P.</creatorcontrib><creatorcontrib>Figueiredo, Taiza H.</creatorcontrib><creatorcontrib>Apland, James P.</creatorcontrib><creatorcontrib>Braga, Maria F.M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Neurotoxicology (Park Forest South)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prager, Eric M.</au><au>Aroniadou-Anderjaska, Vassiliki</au><au>Almeida-Suhett, Camila P.</au><au>Figueiredo, Taiza H.</au><au>Apland, James P.</au><au>Braga, Maria F.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure</atitle><jtitle>Neurotoxicology (Park Forest South)</jtitle><addtitle>Neurotoxicology</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>38</volume><spage>84</spage><epage>90</epage><pages>84-90</pages><issn>0161-813X</issn><eissn>1872-9711</eissn><abstract>•Rats were exposed to soman to induce status epilepticus (SE).•AChE activity was measured in piriform cortex, hippocampus, and basolateral amygdala.•AChE was reduced in all three brain regions of rats that developed SE.•A small percentage of rats did not develop SE.•AChE was not reduced in the basolateral amygdala of rats that did not develop SE. Exposure to nerve agents induces intense seizures (status epilepticus, SE), which cause brain damage or death. Identification of the brain regions that are critical for seizure initiation after nerve agent exposure, along with knowledge of the physiology of these regions, can facilitate the development of pretreatments and treatments that will successfully prevent or limit the development of seizures and brain damage. It is well-established that seizure initiation is due to excessive cholinergic activity triggered by the nerve agent-induced irreversible inhibition of acetylcholinesterase (AChE). Therefore, the reason that when animals are exposed to lethal doses of a nerve agent, a small proportion of these animals do not develop seizures, may have to do with failure of the nerve agent to inhibit AChE in brain areas that play a key role in seizure initiation and propagation. In the present study, we compared AChE activity in the basolateral amygdala (BLA), hippocampus, and piriform cortex of rats that developed SE (SE rats) after administration of the nerve agent soman (154μg/kg) to AChE activity in these brain regions of rats that received the same dose of soman but did not develop SE (no-SE rats). The levels of AChE activity were measured at the onset of SE in SE rats, 30min after soman administration in no-SE rats, as well as in controls which received saline in place of soman. In the control group, AChE activity was significantly higher in the BLA compared to the hippocampus and piriform cortex. Compared to controls, AChE activity was dramatically lower in the hippocampus and the piriform cortex of both the SE rats and the no-SE rats, but AChE activity in the BLA was reduced only in the SE rats. Consistent with the notion that soman-induced neuropathology is due to intense seizures, rather than due to a direct neurotoxic effect of soman, no-SE rats did not present any neuronal loss or degeneration, 7 days after exposure. The results suggest that inhibition of AChE activity in the BLA is necessary for the generation of seizures after nerve agent exposure, and provide strong support to the view that the amygdala is a key brain region for the induction of seizures by nerve agents.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>23817175</pmid><doi>10.1016/j.neuro.2013.06.006</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-813X
ispartof Neurotoxicology (Park Forest South), 2013-09, Vol.38, p.84-90
issn 0161-813X
1872-9711
language eng
recordid cdi_proquest_miscellaneous_1676357028
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcholinesterase
Amygdala - drug effects
Amygdala - enzymology
Animals
Basolateral amygdala
Biological and medical sciences
Brain - drug effects
Brain - pathology
Chemical and industrial products toxicology. Toxic occupational diseases
Cholinesterase Inhibitors - toxicity
Gas, fumes
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Hippocampus
Hippocampus - drug effects
Hippocampus - enzymology
Male
Medical sciences
Nerve Degeneration - chemically induced
Nervous system (semeiology, syndromes)
Neurology
Olfactory Pathways - enzymology
Piriform cortex
Rats
Soman
Soman - toxicity
Status epilepticus
Status Epilepticus - chemically induced
Status Epilepticus - enzymology
Status Epilepticus - pathology
Toxicology
title Acetylcholinesterase inhibition in the basolateral amygdala plays a key role in the induction of status epilepticus after soman exposure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A16%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acetylcholinesterase%20inhibition%20in%20the%20basolateral%20amygdala%20plays%20a%20key%20role%20in%20the%20induction%20of%20status%20epilepticus%20after%20soman%20exposure&rft.jtitle=Neurotoxicology%20(Park%20Forest%20South)&rft.au=Prager,%20Eric%20M.&rft.date=2013-09-01&rft.volume=38&rft.spage=84&rft.epage=90&rft.pages=84-90&rft.issn=0161-813X&rft.eissn=1872-9711&rft_id=info:doi/10.1016/j.neuro.2013.06.006&rft_dat=%3Cproquest_cross%3E1676357028%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1431616683&rft_id=info:pmid/23817175&rft_els_id=S0161813X13001113&rfr_iscdi=true